Tag: VERVE-101

Tag Visualization: Top 50 related tags by occurrence

United States: 1 articleUnited StatesUnited Kingdom: 1 articleUnited KingdomCardiology: 1 articleCardiologyCoronary artery disease: 1 articleCoronary artery dise...Cholesterol: 2 articlesCholesterolGABAA receptor positive allosteric modulators: 1 articleGABAA receptor posit...PCSK9: 2 articlesPCSK9Lipoproteins: 1 articleLipoproteinsLipid metabolism disorders: 1 articleLipid metabolism dis...Familial hypercholesterolemia: 1 articleFamilial hypercholes...Hypercholesterolemia: 1 articleHypercholesterolemiaVerve Therapeutics: 2 articlesVerve TherapeuticsLow-density lipoprotein: 2 articlesLow-density lipoproteinNiacin: 1 articleNiacinDyslipidemia: 1 articleDyslipidemiaPCSK9 inhibitors: 1 articlePCSK9 inhibitorsVERVE-101: 2 articlesVERVE-101

Recent Related Articles to VERVE-101

Verve pauses base editing trial, shifts strategy after treatment side effect | BioPharma Dive

Added to Collection on: 2024-04-02 17:07:22

Tags for this article:

GABAA receptor positive allosteric modulators
PCSK9
VERVE-101
Low-density lipoprotein
Cholesterol
Niacin
United Kingdom
United States
Verve Therapeutics

Click the tags to see associated articles and topics

View Article Details
Verve moves forward with backup base editing therapy - BioPharma Dive

Added to Collection on: 2024-05-07 16:12:04

Tags for this article:

Lipid metabolism disorders
Cardiology
Lipoproteins
PCSK9
PCSK9 inhibitors
VERVE-101
Familial hypercholesterolemia
Low-density lipoprotein
Hypercholesterolemia
Cholesterol
Coronary artery disease
Dyslipidemia
Verve Therapeutics

Click the tags to see associated articles and topics

View Article Details